NYSE:ACBAurora Cannabis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aurora Cannabis Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $11.60 -0.48 (-3.97 %) (As of 07/14/2020 03:34 PM ET) Add Compare Share Today's Range$11.45Now: $11.60▼$12.1250-Day Range$11.77MA: $13.36▼$16.0152-Week Range$5.30Now: $11.60▼$89.52Volume93,818 shsAverage Volume4.05 million shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/ABeta1.78 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.Read More Beat the Market (BTM) Rank™ 4.0 Analyst's Opinion Consensus RatingAurora Cannabis has received a consensus rating of Hold. The company's average rating score is 1.94, and is based on 3 buy ratings, 10 hold ratings, and 4 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $25.23, Aurora Cannabis has a potential upside of 117.2% from its current price of $11.62.Amount of Analyst CoverageAurora Cannabis has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.4 Community Rank Outperform VotesAurora Cannabis has received 368 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAurora Cannabis has received 392 “underperform” votes. (Add your “underperform” vote.)Community SentimentAurora Cannabis has received 51.58% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote “Outperform” if you believe ACB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Aurora Cannabis are expected to grow in the coming year, from ($10.04) to ($0.82) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.52 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolNYSE:ACB Previous Symbol CUSIPN/A CIKN/A Webauroramj.com Phone1-855-279-4652Debt Debt-to-Equity Ratio0.14 Current Ratio3.17 Quick Ratio1.80Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$215.10 million Price / Sales6.11 Cash FlowN/A Price / Cash FlowN/A Book Value$39.12 per share Price / Book0.30Profitability EPS (Most Recent Fiscal Year)($2.64) Net Income$-219,670,000.00 Net Margins-442.62% Return on Equity-8.55% Return on Assets-6.91%Miscellaneous Employees2,779 Outstanding Shares113,250,000Market Cap$1.31 billion Next Earnings Date9/9/2020 (Estimated) OptionableOptionable ACB Rates by TradingView Receive ACB News and Ratings via Email Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Aurora Cannabis (NYSE:ACB) Frequently Asked Questions How has Aurora Cannabis' stock been impacted by COVID-19 (Coronavirus)? Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ACB stock has increased by 12.8% and is now trading at $11.62. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Aurora Cannabis? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 4 sell ratings, 10 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis. When is Aurora Cannabis' next earnings date? Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc (NYSE:ACB) issued its quarterly earnings data on Thursday, May, 14th. The company reported ($0.74) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.21. The firm earned $56.31 million during the quarter, compared to analysts' expectations of $46.93 million. Aurora Cannabis had a negative net margin of 442.62% and a negative return on equity of 8.55%. View Aurora Cannabis' earnings history. When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work? Aurora Cannabis shares reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split. What price target have analysts set for ACB? 17 brokers have issued 12 month price targets for Aurora Cannabis' shares. Their forecasts range from $10.00 to $108.00. On average, they expect Aurora Cannabis' share price to reach $25.23 in the next year. This suggests a possible upside of 117.2% from the stock's current price. View analysts' price targets for Aurora Cannabis. Has Aurora Cannabis been receiving favorable news coverage? Media coverage about ACB stock has been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Aurora Cannabis earned a news impact score of -1.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Aurora Cannabis. Are investors shorting Aurora Cannabis? Aurora Cannabis saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 19,490,000 shares, a drop of 10.9% from the June 15th total of 21,870,000 shares. Based on an average trading volume of 10,100,000 shares, the days-to-cover ratio is presently 1.9 days. Currently, 17.4% of the shares of the stock are sold short. View Aurora Cannabis' Current Options Chain. Who are some of Aurora Cannabis' key competitors? Some companies that are related to Aurora Cannabis include STADA Arzneimittel (STDAF), Cronos Group (CRON), USANA Health Sciences (USNA), Aphria (APHA), Tilray (TLRY), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN), True Drinks (TRUU) and FitLife Brands (FTLF). View all competitors. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), HEXO (HEXO), NVIDIA (NVDA), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU) and General Electric (GE). Who are Aurora Cannabis' key executives? Aurora Cannabis' management team includes the following people: Mr. Michael Singer, Exec. Chairman (Age 54)Mr. Terry Booth, Founder, CEO & Director (Age 54)Mr. Stephen Dobler, Founder, Pres & Director (Age 54)Mr. Glen Ibbott, Chief Financial OfficerMr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer What is Aurora Cannabis' stock symbol? Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB." Who are Aurora Cannabis' major shareholders? Aurora Cannabis' stock is owned by many different retail and institutional investors. Top institutional investors include AdvisorShares Investments LLC (0.01%) and TRUE Private Wealth Advisors (0.00%). Which major investors are selling Aurora Cannabis stock? ACB stock was sold by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, and TRUE Private Wealth Advisors. How do I buy shares of Aurora Cannabis? Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Aurora Cannabis' stock price today? One share of ACB stock can currently be purchased for approximately $11.62. How big of a company is Aurora Cannabis? Aurora Cannabis has a market capitalization of $1.32 billion and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($2.64) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe. What is Aurora Cannabis' official website? The official website for Aurora Cannabis is auroramj.com. How can I contact Aurora Cannabis? Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected] This page was last updated on 7/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
